By Iain Gilbert
Date: Thursday 10 Apr 2025
(Sharecast News) - Software group Cambridge Cognition said on Thursday that it has secured a £1.0m contract to provide digital cognitive assessments for a large Phase 3 autoimmune disease clinical trial.
By Josh White
Date: Wednesday 08 Jan 2025
(Sharecast News) - Cambridge Cognition announced the use of its 'CANTAB' cognitive assessment product in two phase three clinical trials conducted by Bristol Myers Squibb for 'Cobenfy', a newly FDA-approved treatment for schizophrenia.
By Iain Gilbert
Date: Tuesday 10 Dec 2024
(Sharecast News) - Brain health software group Cambridge Cognition said on Tuesay that full-year revenues were expected to be no less than £10.0m, while adjusted underlying earnings was seen at close to breakeven.
Currency | UK Pounds |
Share Price | 37.50p |
Change Today | 0.000p |
% Change | 0.00 % |
52 Week High | 46.50 |
52 Week Low | 27.50 |
Volume | 14,009 |
Shares Issued | 41.94m |
Market Cap | £15.73m |
RiskGrade | 282 |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income | ![]() |
---|
Growth |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Strong Buy | 1 |
Buy | 1 |
Neutral | 0 |
Sell | 0 |
Strong Sell | 0 |
Total | 2 |
No dividends found |
Time | Volume / Share Price |
10:41 | 2,500 @ 39.00p |
08:37 | 9 @ 36.00p |
08:00 | 9,000 @ 39.00p |
08:00 | 9,000 @ 39.00p |
You are here: research